R has made over 5 trades of the Acasti Pharma Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently R exercised 10,000 units of ACST stock worth $23,200 on 15 March 2019.
The largest trade R's ever made was exercising 25,000 units of Acasti Pharma Inc stock on 23 January 2017 worth over $51,000. On average, R trades about 5,455 units every 71 days since 2016. As of 15 March 2019 R still owns at least 580,602 units of Acasti Pharma Inc stock.
You can see the complete history of R Macdonald stock trades at the bottom of the page.
R's mailing address filed with the SEC is 103 CARNEGIE CENTER, SUITE 300, PRINCETON, NJ, 08540.
Over the last 3 years, insiders at Acasti Pharma Inc have traded over $0 worth of Acasti Pharma Inc stock and bought 676,752 units worth $1,252,067 . The most active insiders traders include Vimal Kavuru, John Canan a R. Loch Macdonald. On average, Acasti Pharma Inc executives and independent directors trade stock every 13 days with the average trade being worth of $785,032. The most recent stock trade was executed by Vimal Kavuru on 25 September 2023, trading 676,371 units of ACST stock currently worth $1,251,286.
acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.
Acasti Pharma Inc executives and other stock owners filed with the SEC include: